Despite the increased importance for reliable methods towards synthetically modified proteins, it remains an ongoing challenge to develop strategies that can achieve high chemo- and site-selectivity. In this research, a bioconjugation strategy is developed involving protected triazolinedione moieties (TAD*). TAD*s are bench-stable at room temperature, but deblock upon heating in aqueous medium allowing controlled release and improved site-selective protein modification.